tirzepatide fda label Lilly's Zepbound (aka tirzepatide) Lands Approval for Weight Loss The long awaited twincretin was

If we target this mechanism, this preliminary evidence suggests it may help migraine sufferers. The drug was generally well-tolerated, with about 38% of participants reporting mild side effects like nausea and constipation, but none stopped treatment because of them

It has a well-understood mechanism with a growing body of long-term safety data

On July 10, 2024, Kuei-Pin Huang and colleagues published a paper in Nature titled Dissociable Hindbrain GLP1R Circuits for Satiety and Aversion. The study suggests that future weight loss medications could selectively target GLP1R neurons in the nucleus of the solitary tract (NTS) to avoid inducing aversion, thereby improving treatment adherence and effectiveness [1]

Fasting Blood Glucose Some patients self-monitor daily, others check less often, depending on what their doctor advises